User profiles for Sedigheh Pouya

Sedigheh Pouya

Department of Immunology, Faculty of Medicine, Shahid Beheshti University of Medical …
Verified email at sbmu.ac.ir
Cited by 129

Study the effects of mesenchymal stem cell conditioned medium injection in mouse model of acute colitis

S Pouya, M Heidari, K Baghaei, HA Aghdaei… - International …, 2018 - Elsevier
Background and aim Inflammatory bowel disease (IBD) is an autoimmune-inflammatory
disorder that results in inflammatory responses in individuals who are genetically susceptible. …

The immunomodulatory effects of adipose‐derived mesenchymal stem cells and mesenchymal stem cells‐conditioned medium in chronic colitis

M Heidari, S Pouya, K Baghaei… - Journal of Cellular …, 2018 - Wiley Online Library
Inflammatory bowel disease (IBD) as a chronic recurrent disorder is characterized by
mucosal immune response dysregulation, which is more prevalent in the youth. Adipose‐derived …

SARS-CoV-2 mRNA-vaccine candidate; COReNAPCIN®, induces robust humoral and cellular immunity in mice and non-human primates

…, K Nasrollahi, T Malekshahabi, M Heidari, S Pouya… - NPJ vaccines, 2022 - nature.com
At the forefront of biopharmaceutical industry, the messenger RNA (mRNA) technology offers
a flexible and scalable platform to address the urgent need for world-wide immunization in …

Safety and immunogenicity of COReNAPCIN, a SARS-CoV-2 mRNA vaccine, as a fourth heterologous booster in healthy Iranian adults: A double-blind, randomized …

…, A Nematollahi, M Alimohammadi, S Pouya… - International …, 2024 - Elsevier
The recurrent COVID-19 infection, despite global vaccination, highlights the need for booster
doses. A heterologous booster has been suggested to enhance immunity and protection …

Safety and immunogenicity of COReNAPCIN®, a SARS-CoV-2 mRNA vaccine; a randomized, double-blind, placebo-controlled phase 1 clinical trial

…, A Nematollahi, M Alimohammadi, S Pouya… - medRxiv, 2023 - medrxiv.org
The repeated COVID-19 outbreaks, despite global vaccination, highlights the need for booster
doses. Here, we present the outcomes, up until day 90 post vaccination, of a randomized, …

mRNA-based vaccine candidate COReNAPCIN® induces robust humoral and cellular immunity in mice and non-human primates

…, K Nasrollahi, T Malekshahabi, M Heidari, S Pouya… - bioRxiv, 2022 - biorxiv.org
At the forefront of biopharmaceutical industry, the messenger RNA (mRNA) technology offers
a flexible and scalable platform to address the urgent need for world-wide immunization in …

[PDF][PDF] Comparative Effects of Different Doses of Dextran Sodium Sulfate on the Induction of Chronic Colitis in C57BL/6 Mice

M Heidari, S Pouya, SM Hashemi… - Research in …, 2020 - pejouhesh.sbmu.ac.ir
… Maryam Heidari1, Sedigheh Pouya1, Seyed Mahmoud Hashemi 1, 2, Kaveh Baghaei 3,
Mohammad Reza Zali 4 … Pouya S, Heidari M, Baghaei K, Asadzadeh Aghdaei H, Moradi …

mRNA-based vaccine candidate COReNAPCIN (R) induces robust humoral and cellular immunity in mice and non-human primates (preprint)

…, K Nasrollah, T Malekshahab, M Heidari, S Pouya… - 2022 - pesquisa.bvsalud.org
At the forefront of biopharmaceutical industry, the messenger RNA (mRNA) technology offers
a flexible and scalable platform to address the urgent need for world-wide immunization in …

The Effects of Adipose-Derived Mesenchymal Stem Cells Conditioned Media in Clinical Feature of Dextran sulfate sodium Induced Colitis

S Pouya - sid.ir
… Presenter Author: Sedigheh PouyaSedigheh Pouya1, Seyed Mahmoud Hashemi2,
Kaveh Baghaei3, Mohammad Reza Zali4 …

THE EFFECTS OF ADIPOSE-DERIVED MESENCHYMAL STEM CELLS CONDITIONED MEDIA IN CLINICAL FEATURE OF DEXTRAN SULFATE SODIUM INDUCED …

S POUYA, SM HASHEMI, K BAGHAEI, MR ZALI - 2017 - sid.ir
BACKGROUND AND AIM: INFLAMMATORY BOWEL DISEASE (IBD) IS A CHRONIC
INFLAMMATORY CONDITION OF THE GASTROINTESTINAL TRACT. THE MUCOSAL IMMUNE …